Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant Disease

Conditions

• Metastatic Breast Cancer in the Liver

Interventions

• DRUG: Melphalan/HDS followed by Physician's choice of SOC (eribulin, vinorelbine, or capecitabine)
• DRUG: Physician's choice of SOC (eribulin, vinorelbine, or capecitabine)

Sponsor

Delcath Systems Inc.